Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma-Reference-Cited by-同舟云学术

Radiotherapy opens the blood–brain barrier and synergizes with anlotinib in treating glioblastoma

Published:2023-06 Issue: Volume:183 Page:109633
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Li Pei-Jing,Lai Shu-Zhen,Jin Ting,Ying Hang-Jie,Chen Ya-Mei,Zhang Peng,Hang Qing-Qing,Deng Huan,Wang Lei,Feng Jian-Guo,Chen Xiao-Zhong,Guo Peng,Chen Ming,Tian Ye,Chen Yuan-Yuan

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Glioblastoma and other malignant gliomas: a clinical review;Omuro;J Am Med Assoc,2013

2. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012;14:v1-49. doi:10.1093/neuonc/nos218

3. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

4. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor;Xie;Cancer Sci,2018

5. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway;He;Biochem Biophys Res Commun,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases;Frontiers in Pharmacology;2024-08-19

2. Case report: Pyrotinib and tegafur combined with radiotherapy achieved notable response in HER2-amplified rectal cancer with multiple metastases after multiline treatments;Frontiers in Pharmacology;2024-08-13

3. Pyrimidine compounds BY4003 and BY4008 inhibit glioblastoma cells growth via modulating JAK3/STAT3 signaling pathway;Neurotherapeutics;2024-08

4. Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models;Cancers;2024-07-24

5. Radiotherapy plus temozolomide with or without anlotinib in H3K27M‐mutant diffuse midline glioma: A retrospective cohort study;CNS Neuroscience & Therapeutics;2024-04